Thrombocytopenia in children.
Thrombocytopenia in children can be classified on the basis of understanding of the production, life span, and fate of platelets. Thrombocytopenia may be familial, associated with drug-ingestion as a result of immune mediated mechanisms, direct toxicity to circulating platelets, or injury to megakaryocytes, or associated with other disease states.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000743:Anemia, Hemolytic / Q000150:complications; D000927:Anticonvulsants / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000150:complications; D001792:Blood Platelets / Q000166:cytology; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis; D007239:Infections / Q000150:complications; D010976:Platelet Count; D011696:Purpura, Thrombocytopenic / Q000503:physiopathology; D012877:Skin Manifestations; D013154:Spleen / Q000276:immunology; D013156:Splenectomy; D013163:Splenomegaly / Q000150:complications; D013577:Syndrome; D013921:Thrombocytopenia / Q000097:blood* / Q000150:complications / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D007074:Immunoglobulin G; D003165:Complement System Proteins